Long COVID: systemic inflammation and obesity as therapeutic targets
- PMID: 35472305
- PMCID: PMC9034853
- DOI: 10.1016/S2213-2600(22)00159-X
Long COVID: systemic inflammation and obesity as therapeutic targets
Conflict of interest statement
We declare no competing interests.
Comment on
-
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.Lancet Respir Med. 2022 Aug;10(8):761-775. doi: 10.1016/S2213-2600(22)00127-8. Epub 2022 Apr 23. Lancet Respir Med. 2022. PMID: 35472304 Free PMC article.
References
-
- The PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00127-8. published online April 23. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical